These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 26400309)

  • 1. Arg188His polymorphism in the XRCC2 gene and the risk of ovarian cancer: a meta-analysis.
    Zhai M; Wang Y; Jiang MF
    Genet Mol Res; 2015 Sep; 14(3):10808-15. PubMed ID: 26400309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between single nucleotide polymorphisms (SNPs) of XRCC2 and XRCC3 homologous recombination repair genes and ovarian cancer in Polish women.
    Michalska MM; Samulak D; Romanowicz H; Jabłoński F; Smolarz B
    Exp Mol Pathol; 2016 Apr; 100(2):243-7. PubMed ID: 26801223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Arg188His polymorphism in the XRCC2 gene and the risk of cancer.
    Zhang Y; Wang H; Peng Y; Liu Y; Xiong T; Xue P; Du L
    Tumour Biol; 2014 Apr; 35(4):3541-9. PubMed ID: 24414483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of XRCC2 Arg188His polymorphism on cancer susceptibility: a meta-analysis.
    He Y; Zhang Y; Jin C; Deng X; Wei M; Wu Q; Yang T; Zhou Y; Wang Z
    PLoS One; 2014; 9(3):e91202. PubMed ID: 24621646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. XRCC2 Arg188His polymorphism and colorectal cancer risk: a meta-analysis.
    Wang Z; Wei Y; An L; Xi C; Wang K; Hong D; Shi Y; Zang A; Su S; Li W
    J Int Med Res; 2021 Oct; 49(10):3000605211039473. PubMed ID: 34648414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. XRCC2 Arg188His polymorphism is not directly associated with breast cancer risk: evidence from 37,369 subjects.
    Yu KD; Chen AX; Qiu LX; Fan L; Yang C; Shao ZM
    Breast Cancer Res Treat; 2010 Aug; 123(1):219-25. PubMed ID: 20127279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of association between XPG Asp1104His and XPF Arg415Gln polymorphism and breast cancer risk: a meta-analysis of case-control studies.
    Ding DP; He XF; Zhang Y
    Breast Cancer Res Treat; 2011 Aug; 129(1):203-9. PubMed ID: 21424776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MTHFR A1298C polymorphism and ovarian cancer risk: a meta-analysis.
    Shi XY; Shen Q
    Genet Mol Res; 2015 Jul; 14(3):8211-8. PubMed ID: 26345746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between XRCC2 Arg188His Polymorphism and Breast Cancer Susceptibility: A Systematic Review and Meta-Analysis.
    Dastgheib SA; Sayad S; Azizi S; Hajizadeh N; Asadian F; Karimi-Zarchi M; Barahman M; Shiri A; Manzourolhojeh M; Aghili K; Neamatzadeh H
    Asian Pac J Cancer Prev; 2024 Jan; 25(1):43-55. PubMed ID: 38285766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. XRCC1 genetic polymorphism Arg399Gln and hepatocellular carcinoma risk: a meta-analysis.
    Liu F; Li B; Wei Y; Yan L; Wen T; Zhao J; Xu M
    Liver Int; 2011 Jul; 31(6):802-9. PubMed ID: 21645210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analysis demonstrates no association between XRCC1 Arg399Gln polymorphism and bladder cancer risk.
    Dong LM; Zhang XY; Teng H; Li MS; Wang P
    Genet Mol Res; 2014 Nov; 13(4):9976-85. PubMed ID: 25501209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between a single nucleotide polymorphism in the TP53 region and risk of ovarian cancer.
    Xi Y; Liu C; Xin X
    Cell Biochem Biophys; 2014 Dec; 70(3):1907-12. PubMed ID: 25060098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between the XRCC1 Arg399Gln polymorphism and risk of cervical carcinoma: a meta-analysis.
    Liu DY; Liang HC; Xiao XM
    Genet Mol Res; 2015 Aug; 14(3):9821-8. PubMed ID: 26345915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphism of DNA Repair Genes via Homologous Recombination (HR) in Ovarian Cancer.
    Smolarz B; Michalska MM; Samulak D; Romanowicz H; Wójcik L
    Pathol Oncol Res; 2019 Oct; 25(4):1607-1614. PubMed ID: 30712190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of RAD51 135 G>C and XRCC2 G>A (rs3218536) polymorphisms on ovarian cancer risk among Caucasians: a meta-analysis.
    Shi S; Qin L; Tian M; Xie M; Li X; Qi C; Yi X
    Tumour Biol; 2014 Jun; 35(6):5797-804. PubMed ID: 24599673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA repair gene X-ray repair cross complementing group 1 Arg194Trp polymorphism on the risk of lung cancer: a meta-analysis on 22 studies.
    Jiang J; Liang X; Zhou X; Huang R; Chu Z; Zhan Q; Lin H
    J Thorac Oncol; 2010 Nov; 5(11):1741-7. PubMed ID: 20975374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of XRCC2 rs3218536 Polymorphism with Susceptibility of Breast and Ovarian Cancer: A Systematic Review and Meta-Analysis.
    Kamali M; Hamadani S; Neamatzadeh H; Mazaheri M; Zare Shehneh M; Modaress Gilani M; Haghighi F
    Asian Pac J Cancer Prev; 2017 Jul; 18(7):1743-1749. PubMed ID: 28749098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphism of DNA repair gene xrcc1 and lung cancer risk.
    Wang H; Liu Z
    Cell Biochem Biophys; 2014 Dec; 70(3):1881-6. PubMed ID: 25038912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. XRCC1 genetic polymorphisms and bladder cancer susceptibility: a meta-analysis.
    Wang C; Sun Y; Han R
    Urology; 2008 Oct; 72(4):869-72. PubMed ID: 18336890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association of SULT1A1 codon 213 polymorphism and breast cancer susceptibility: meta-analysis from 16 studies involving 23,445 subjects.
    Sun Y; Zang Z; Xu X; Zhang Z; Zhong L; Zan W; Zhao Y; Sun L
    Breast Cancer Res Treat; 2011 Jan; 125(1):215-9. PubMed ID: 20505990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.